See other companies on Welcome to the Jungle
Mootral
AgriTech for carbon reduction
- 21-100 employees
- B2B
- Sustainability
- Manufacturing
- Biology
- Agriculture
- Abertillery, UK
Jump to section
Company mission
To unlock new, innovative and profitable approaches to reducing GHG emissions.
Our take
Mootral’s one-of-a-kind product is sure to catch the attention of the press as it grows as a company. Mootral Ruminant is a feed supplement for livestock, especially cows, that reduces the amount of methane released by waste gas by up to 38%. As the largest natural carbon emission creator, the natural supplement can easily be added to feed and is an ingenious aid in the fight against climate change.
Mootral’s three founders have a varied history that makes them the perfect match for the AgriTech business. Combining supply chain management, software development, and bio and MedTech, it’s easy to see how Mootral came to be. Running off the success of Mootral Ruminant, the company is now focusing on the fight against antibiotic resistance in livestock, another key strategy to elevate the agriculture industry.
The Swiss-British company is part of a growing trend of carbon reduction organisations emerging across various markets. The benefits for investors include “carbon credits”, providing other companies with a route to offset their emissions through funding Mootral and helping finance Ruminant’s production costs. With Mootral’s obtaining a series of grants, VC, and seed funding since its founding in 2018, the financial strategy is benefitting both the AgriTech firm and its investors but has many competitors with larger amounts of money under its belts across the world.
Steph
Company Specialist at Welcome to the Jungle
Company values
- Bold and Memorable - Mootral is never afraid to say what we think. Challenge the status quo. Provoke reactions.
- Genuine - Mootral doesn't just love what it does, it believes in it too.
- Pioneers - Doing what’s been done before brings the same results.
Funding (last 2 of 3 rounds)
Feb 2020
$7.7m
EARLY VC
May 2019
$0.3m
GRANT
Total funding: $18.5m
This company has top investors
Leadership
Thomas Hafner
(Co-Founder & CEO)Currently Co-Founder and Executive Chairman at Zaluvida Ventures, InQpharm, Neem Biotech Limited and Onya Therapeutics .
Isabella Botticelli
(Co-Founder & COO)Previously VP Supply Chain & Quality at Zaluvida Ventures, Customer Supply Chain at GSK, Supply Chain Head at Novartis, Supply Chain Planning at Unilever.
Chris Kantrowitz
(Co-Founder)Currently CEO at Gobbler, Member of the Board of Directors at The Sanders Institute, Investor at Beckley Psytech.